CIBC World Markets »

Kailera Therapeutics shares owned by CIBC World Markets

Quarter-by-quarter ownership of Kailera Therapeutics shares owned by CIBC World Markets from 13F filings

Historical chart of CIBC World Markets investment in Kailera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kailera Therapeutics held by CIBC World Markets consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kailera Therapeutics by CIBC World Markets

Quarter filed Position value Share count Share price at filing
2026-06-30 $782k 36k 22.03

More positions owned by CIBC World Markets

Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Bk Nova Cad (BNS)
Nvidia Corporation Call Call Option
Enbridge (ENB)
Cibc Cad (CM)
Canadian Natural Resources (CNQ)
Tc Energy Corp (TRP)
Shopify Cl A Sub Vtg (SHOP)
Apple (AAPL)
NVIDIA Corporation (NVDA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Brookfield Corp Cl A Ltd Vt (BN)

View all positions for CIBC World Markets

Top funds holding Kailera Therapeutics

Bain Capital Investors
Bain Capital Life Sciences Investors
Rtw Investments
Canada Pension Plan Investment Board
Atlas Venture Life Science Advisors
FMR
BlackRock
Citadel Advisors
Adage Capital Partners GP
Wellington Management Company
Royalty Pharma Sub-Manager
Siren
Vanguard Capital Management
Vanguard Portfolio Management
Geode Capital Management

View all funds holding Kailera Therapeutics